| Entry |
|
|---|
| Name |
Mirogabalin (USAN/INN) |
|---|
| Formula |
C12H19NO2
|
|---|
| Exact mass |
209.1416
|
|---|
| Mol weight |
209.28
|
|---|
| Structure |
|
|---|
| Remark |
| Product (DG02947): | D10790<JP> |
|
|---|
| Efficacy |
Pain relief |
|---|
| Comment |
Treatment of fibromyalgia
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02B OTHER ANALGESICS AND ANTIPYRETICS
N02BF Gabapentinoids
N02BF03 Mirogabalin
D11203 Mirogabalin (USAN/INN)
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA2D1
D11203 Mirogabalin (USAN/INN)
CACNA2D2
D11203 Mirogabalin (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 15
1 C1y C 18.2665 -16.5201
2 C1y C 18.2665 -15.1141
3 C1x C 19.6725 -15.1141
4 C1z C 19.6725 -16.5201
5 C2x C 16.9308 -16.9419
6 C2y C 16.0872 -15.8171
7 C1x C 16.9308 -14.6923
8 C1b C 14.6813 -15.8171
9 C1a C 13.9783 -14.6220
10 C1b C 20.8676 -17.2231
11 C6a C 22.0627 -16.5201
12 O6a O 23.2578 -17.2231
13 O6a O 22.0627 -15.1141
14 C1b C 19.6725 -17.9261
15 N1a N 20.8676 -18.6291
BOND 16
1 1 2 1
2 2 3 1
3 3 4 1
4 1 4 1
5 1 5 1
6 5 6 2
7 6 7 1
8 2 7 1
9 6 8 1
10 8 9 1
11 10 4 1
12 10 11 1
13 11 12 1
14 11 13 2
15 4 14 1 #Up
16 14 15 1
|
|---|
